Asensus Surgical Inc (ASXC) Shares Plummet Below 1-Year High

Asensus Surgical Inc (AMEX: ASXC) has experienced a decline in its stock price by -3.00 compared to its previous closing price of 0.22. However, the company has seen a fall of -11.45% in its stock price over the last five trading days. GlobeNewsWire reported 2024-03-15 that RESEARCH TRIANGLE PARK, N.C., March 15, 2024 (GLOBE NEWSWIRE) — Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient, announced today that it plans to release fourth quarter and full year 2023 financial and operating results after the market closes on Thursday, March 21, 2024. The Company will host a conference call to discuss these results starting at 4:30 p.m. ET the same day. The call will be concurrently webcast.

Is It Worth Investing in Asensus Surgical Inc (AMEX: ASXC) Right Now?

Additionally, the 36-month beta value for ASXC is 1.48. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The public float for ASXC is 266.52M and currently, short sellers hold a 6.38% ratio of that float. The average trading volume of ASXC on April 03, 2024 was 1.20M shares.

ASXC’s Market Performance

The stock of Asensus Surgical Inc (ASXC) has seen a -11.45% decrease in the past week, with a -30.03% drop in the past month, and a -33.08% fall in the past quarter. The volatility ratio for the week is 7.20%, and the volatility levels for the past 30 days are at 7.01% for ASXC. The simple moving average for the last 20 days is -21.94% for ASXC’s stock, with a simple moving average of -32.40% for the last 200 days.

Analysts’ Opinion of ASXC

Cantor Fitzgerald, on the other hand, stated in their research note that they expect to see ASXC reach a price target of $1.50. The rating they have provided for ASXC stocks is “Overweight” according to the report published on September 08th, 2022.

H.C. Wainwright gave a rating of “Buy” to ASXC, setting the target price at $4 in the report published on May 26th of the previous year.

ASXC Trading at -24.23% from the 50-Day Moving Average

After a stumble in the market that brought ASXC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -75.19% of loss for the given period.

Volatility was left at 7.01%, however, over the last 30 days, the volatility rate increased by 7.20%, as shares sank -31.14% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -27.34% lower at present.

During the last 5 trading sessions, ASXC fell by -11.45%, which changed the moving average for the period of 200-days by -60.48% in comparison to the 20-day moving average, which settled at $0.2686. In addition, Asensus Surgical Inc saw -33.08% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at ASXC starting from Starling William N JR, who purchase 18,134 shares at the price of $0.28 back on Dec 14 ’23. After this action, Starling William N JR now owns 39,134 shares of Asensus Surgical Inc, valued at $5,078 using the latest closing price.

Starling William N JR, the Director of Asensus Surgical Inc, sale 18,134 shares at $0.28 during a trade that took place back on Dec 14 ’23, which means that Starling William N JR is holding 0 shares at $5,078 based on the most recent closing price.

Stock Fundamentals for ASXC

Current profitability levels for the company are sitting at:

  • -9.13 for the present operating margin
  • -0.55 for the gross margin

The net margin for Asensus Surgical Inc stands at -9.14. The total capital return value is set at -1.63. Equity return is now at value -117.89, with -88.23 for asset returns.

Based on Asensus Surgical Inc (ASXC), the company’s capital structure generated 0.15 points at debt to capital in total, while cash flow to debt ratio is standing at -11.2.

Currently, EBITDA for the company is -74.4 million with net debt to EBITDA at 0.15. When we switch over and look at the enterprise to sales, we see a ratio of 5.44. The receivables turnover for the company is 2.44for trailing twelve months and the total asset turnover is 0.14. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.88.


In conclusion, Asensus Surgical Inc (ASXC) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Related Posts